NF-AT derived polypeptides that bind calcineurin and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 24, 2004
Grant Date -
N/A
app pub date -
Apr 14, 2000
filing date -
Apr 14, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Calcineurin (CN)-binding regions in the N-terminal domain derived from NF-ATx is disclosed. Also disclosed are CN-binding polypeptide compositions, DNA segments encoding these polypeptides, and methods of use. The CN-binding polypeptides bind to CN, suppressing the interaction between NF-AT and CN. The CN-binding polypeptide compositions can be used for treating pharmacological intervention with Ca.sup.2+ -dependent signaling events. The CN-binding polypeptide or DNA segments encoding them can be used to assay and screen candidates of pharmaceuticals, in particular, in the evaluation and characterization of immunosuppressants specifically interfering with the interaction between NF-AT and CN.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully